Fact CheckerSign in

NCT06326879Recruiting

A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients

Early-Onset Colorectal Cancer Versus Late-Onset Colorectal Cancer: a Prospective Observational Cohort Study to Explore the Clinical, Sociodemographic, Genetic, and Molecular Characteristics Associated With Adverse Oncological Outcomes (

Source: ClinicalTrials.gov · Last updated 25 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to investigate the clinical, socioeconomic, behavioral, genetic, and molecular factors characterizing Early Onset Colorectal Cancer (EOCRC) patients compared with Late Onset Colorectal Cancer (LOCRC) patients

Status (registry)
Recruiting
Study type
Observational
Enrollment
340 (estimated)
First submitted
18 Mar 2024
Start date
30 Nov 2023
Primary completion date
31 Dec 2026
Lead sponsor
Istituto Clinico Humanitas
NCT number
NCT06326879

What you commit to

  • Study type: Observational
  • Planned participants: 340
  • From 30 Nov 2023 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients undergoing palliative surgery (for example, fecal diversion).
  • Patients with a surgical indication for benign lesions (for example, adenoma or dysplasia).
  • Patients with a concomitant diagnosis of Inflammatory Bowel Disease.

Other illness

  • Patients with metastatic disease at diagnosis.
  • Patients with a known genetic syndrome (for example, Lynch syndrome or Familial Adenomatous Polyposis).

Other

  • Patients requiring an emergent procedure.
  • Patients with an intraoperative finding of a lesion other than adenocarcinoma will be withdrawn from the study.
  • Patients with an intraoperative finding of distal metastasis or peritoneal carcinosis will be withdrawn from the study.

Who the study is looking for

  • Patients aged more than 18 years old at the time of inclusion.
  • Patients with a proven diagnosis of colorectal adenocarcinoma, as reported by the staging histological biopsies.
  • Patients with a preoperative staging I-III.
  • Patients scheduled for elective curative colorectal resection.
  • Patients with rectal cancer who underwent neoadjuvant therapy can be included in the study.
  • Patients able and willing to comply with the protocol requirements (samples' collection and questionnaires' compilation).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Humanitas Research Hospital
Coordinator of this site? Confirm its status
RozzanoItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.